Low Testosterone Symptoms in Women (2026 Guide)

Low testosterone symptoms in women are routinely missed — or blamed on stress, aging, or depression — because most clinicians don't test for them. This guide walks through what low testosterone actually looks like in women, which lab markers confirm it, and when treatment makes clinical sense.

TL;DR: Low testosterone in women produces fatigue, low libido, brain fog, muscle loss, and mood instability that look identical to burnout or early menopause. A total testosterone level below 15–25 ng/dL in a premenopausal woman (or below 10 ng/dL postmenopause) is clinically meaningful. In 2026, licensed clinicians at GoodLife Health review lab results and build personalized hormone protocols — including testosterone therapy for women — without requiring you to argue for testing. The single most important step is getting the right panel, interpreted in context.

Why testosterone matters in women

Testosterone is not a male hormone. Women produce it in the ovaries and adrenal glands throughout their lives, and it drives libido, lean muscle, bone density, mood stability, and cognitive sharpness. Levels peak in the mid-20s and decline roughly 1–2% per year after that. By perimenopause, many women have lost 50% or more of their peak output.

The clinical problem in 2026 is not that low testosterone is rare — it's that it's underdiagnosed. There is no FDA-approved testosterone product for women in the US, which means many conventional clinicians won't prescribe it and won't test for it proactively. The result: women with a treatable hormonal deficiency spend months or years in the wrong treatment lane.

What you'll need to identify low testosterone

• A baseline hormone panel: total testosterone, free testosterone, SHBG (sex hormone-binding globulin), DHEA-S
• Estradiol and progesterone levels (testosterone doesn't act in isolation)
• TSH and free T3/T4 (thyroid dysfunction mimics many of the same symptoms)
• A clinician who reads the numbers in context, not just flags them against a lab reference range built for men
• A symptom log covering 4–8 weeks: energy, libido, sleep quality, mood, and physical recovery after exercise

Step 1 — Map your symptoms against the clinical pattern

Low testosterone in women does not show up as one dramatic symptom. It shows up as a cluster that builds slowly and gets normalized.

The six most documented symptoms, with clinical grounding:

Persistent fatigue that sleep doesn't fix. Testosterone drives mitochondrial energy production in muscle tissue. When levels drop, physical and mental fatigue sets in regardless of sleep hours. If you wake up tired after 8 hours, this is the right flag to pursue.

Low or absent libido. This is the most consistently reported symptom in published research. A 2019 systematic review in the Journal of Clinical Endocrinology & Metabolism found that testosterone therapy produced statistically significant improvements in sexual function for postmenopausal women across 36 randomized controlled trials. The symptom is not psychological — it has a measurable hormonal substrate.

Brain fog and difficulty concentrating. Testosterone receptors are present in the prefrontal cortex. Low levels correlate with word-retrieval problems, poor working memory, and a general sense of mental slowing. Women often describe this as "thinking through wet cement."

Loss of muscle mass and increased body fat. Testosterone is the primary driver of lean mass in women, just as it is in men. Without adequate levels, strength training produces less result and fat accumulates preferentially around the abdomen — a pattern often misread as menopause weight gain.

Mood instability, anxiety, and flat affect. Low testosterone is associated with increased cortisol sensitivity and reduced dopaminergic activity. The presentation often looks like subclinical depression: not severely low, but consistently flat, irritable, or anxious without an identifiable trigger.

Bone density loss. Testosterone contributes to bone mineral density independently of estrogen. Women with chronically low testosterone show faster bone loss, which shows up on a DEXA scan before it shows up as a fracture.

Expected outcome after Step 1: You have a specific symptom list tied to clinical categories, not a vague sense of "not feeling right." This makes the next conversation with a clinician faster and more productive.

Common mistake: Treating each symptom as a separate problem. Fatigue → sleep specialist. Low mood → antidepressant. Low libido → therapy. Each of those consults may be appropriate, but if the underlying hormonal deficit is not corrected, none of them fully resolve the picture.

Step 2 — Get the right labs, ordered correctly

Standard annual bloodwork does not include free testosterone. You have to ask for it — or use a clinician who orders it proactively.

The panel that gives you a usable picture:

• Total testosterone — the baseline. In women, normal range is roughly 15–70 ng/dL, but many women with symptoms fall in the 10–25 ng/dL range and are told their levels are "normal."
• Free testosterone — the fraction not bound to SHBG. This is clinically more relevant than total testosterone because SHBG fluctuates with estrogen levels, oral contraceptives, and liver function. A woman can have a mid-range total testosterone but very low free testosterone if SHBG is high.
• SHBG — elevated SHBG (common in women on oral estrogen or birth control pills) suppresses free testosterone even when production is adequate. Knowing this changes the treatment strategy.
• DHEA-S — the adrenal precursor to testosterone. Low DHEA-S points to adrenal insufficiency as a contributing factor.

Timing matters. Draw labs in the morning (hormones are highest between 7–10 a.m.) and not during the luteal phase if you are still cycling, when progesterone dominates and can mask other values.

Common mistake: Using a direct-to-consumer lab that reports only total testosterone and compares it against a reference range built from male data. The interpretation is wrong before you open the PDF.

Step 3 — Interpret results in clinical context, not in isolation

A number without context is noise. A total testosterone of 18 ng/dL means something different depending on your age, SHBG level, symptoms, and whether you're in perimenopause.

Three scenarios where women get misread:

1. Total testosterone is "normal" but free testosterone is low. High SHBG — often driven by oral estrogen or thyroid changes — binds most of the available testosterone, leaving almost none bioavailable. This woman feels all the symptoms of low testosterone but is told her labs are fine.
2. Labs are ordered but not trended. A single draw at 22 ng/dL tells you less than two draws 6 weeks apart. If the level is declining and symptoms are worsening, that trajectory is the clinical signal.
3. Thyroid and testosterone are both low, but only one is treated. Hypothyroidism and low testosterone produce overlapping symptoms — fatigue, weight gain, brain fog, low mood. Correcting only the thyroid (or only the testosterone) produces partial improvement and confusion about why the patient still doesn't feel well.

At GoodLife Health, clinicians review the full panel — not just the flagged values — and cross-reference lab results with your symptom history before recommending a protocol. That's a different clinical process than getting a single number emailed to you with a note that everything is in range.

Step 4 — Understand your treatment options

If labs and symptoms confirm low testosterone, the current evidence-based options for women are:

Testosterone cream or gel (compounded). Because no FDA-approved product exists for women, compounded topical testosterone is the standard clinical approach in 2026. Doses are 1/10th to 1/20th of male doses — typically 0.5–2 mg/day applied to the inner forearm or inner thigh. Effects on libido and energy are often noticeable within 4–8 weeks; full effect on muscle and bone takes 3–6 months.

Pellet therapy. Testosterone pellets inserted subcutaneously every 3–4 months provide stable levels without daily application. Pellet dosing for women ranges from 50–150 mg depending on body weight, baseline levels, and symptom severity. GoodLife Health's learning center covers hormone pellet therapy in detail — including how clinicians calibrate dose for women specifically.

DHEA supplementation. For women whose low testosterone traces to low adrenal output (low DHEA-S), DHEA supplementation at 10–25 mg/day can raise testosterone levels modestly without direct testosterone administration. This is not a substitute for testosterone therapy when levels are clinically low, but it's a relevant adjunct.

What doesn't work: over-the-counter "testosterone boosters." None of the marketed supplements — zinc, ashwagandha, fenugreek — produce measurable changes in total or free testosterone in peer-reviewed trials at clinically meaningful doses.

Common mistake: Starting treatment without establishing a baseline. If you don't know your starting level, you can't know whether therapy is working or whether your dose needs adjustment.

Step 5 — Monitor, adjust, and trend

Testosterone therapy in women is not set-it-and-forget-it. The goal is symptom resolution at the lowest effective dose, not a number on a lab report.

Monitoring schedule for the first year:

• Repeat labs at 6–8 weeks after starting therapy
• Symptom check-in at the same interval
• SHBG recheck at 3 months if initial SHBG was elevated
• Annual DEXA scan if bone density is a clinical concern

Watch for signs of excess: acne, hair thinning at the temples, increased body hair, or voice changes. These are dose-dependent and reversible with dose reduction — but they require active monitoring, not a one-year gap between appointments.

For women in perimenopause, testosterone therapy often works best alongside estrogen and progesterone optimization. Estrogen protects the uterine lining and reduces cardiovascular risk; progesterone balances estrogen's proliferative effects. Treating testosterone in isolation, when estrogen is also low, produces a partial response. The full picture of hormone optimization for women in perimenopause involves all three hormones, calibrated together.

Troubleshooting

Symptoms persist after 8 weeks on testosterone cream. Check free testosterone — absorption varies. Some women absorb poorly through skin and need a different delivery method. Also recheck SHBG; if it has risen (common with concomitant oral estrogen), free testosterone may still be suppressed despite adequate dosing.

Acne or oily skin starts 3–4 weeks in. Dose is likely too high. Reduce by 25–30% and reassess at 4 weeks. This is one of the most common reasons women discontinue therapy unnecessarily; a dose adjustment almost always resolves it.

Libido improves but fatigue does not. Fatigue that persists after testosterone is corrected usually points to an unaddressed co-factor: thyroid (check reverse T3 if free T3/T4 is low-normal), iron (ferritin below 50 ng/mL impairs energy regardless of hemoglobin), or chronic sleep fragmentation.

Lab levels look good but you still feel flat. Free testosterone may be adequate but another hormone may be deficient. Progesterone has its own mood and sleep effects. Low progesterone with adequate testosterone produces exactly this picture — feeling better but not well.

Partner or provider skeptical of testosterone for women. The evidence base is solid. The 2019 Global Consensus Statement on Testosterone Therapy for Women, endorsed by major endocrinology and gynecology societies globally, concludes that testosterone therapy is safe and effective for hypoactive sexual desire disorder in postmenopausal women, and that physiological use does not produce androgenic side effects. This is not experimental; it's under-applied.

FAQ

What are the most common low testosterone symptoms in women? The most consistently reported are low libido, persistent fatigue, brain fog, loss of lean muscle, mood instability, and difficulty recovering from exercise. These symptoms overlap significantly with burnout and perimenopause, which is why a lab panel is necessary to isolate the cause.

What is a low testosterone level for a woman? Total testosterone below 15 ng/dL is generally considered low in premenopausal women. But free testosterone is clinically more relevant — a woman with a total of 20 ng/dL and high SHBG may have essentially no bioavailable testosterone. The number must be read in context.

Can low testosterone cause weight gain in women? Yes. Testosterone supports lean muscle mass, which drives resting metabolic rate. When muscle declines, the body burns fewer calories at rest. The result is fat gain — particularly visceral fat — even without changes in diet or activity.

Is testosterone therapy safe for women? At physiological doses (not supraphysiological), the safety profile is well-established. The 2019 Global Consensus Statement found no increased cardiovascular or breast cancer risk at doses that restore levels to the normal female range. Androgenic side effects (acne, hair changes) are dose-dependent and reversible.

How long does it take for testosterone therapy to work in women? Libido and mood typically respond within 4–8 weeks. Muscle composition and bone density changes take 3–6 months. Full clinical assessment should not happen before the 3-month mark.

Can you have low testosterone during perimenopause? Yes. Testosterone declines in parallel with estrogen during perimenopause, and the symptoms compound. Many women in perimenopause have both low estrogen and low testosterone but are only prescribed estrogen, which explains partial symptom relief.

Does birth control lower testosterone in women? Oral contraceptives raise SHBG significantly, which binds free testosterone and reduces its bioavailability. A woman on the pill can have normal total testosterone and near-zero free testosterone. This is one of the most underrecognized causes of low-testosterone symptoms in younger women.

How do I get tested for low testosterone as a woman? Request a panel that includes total testosterone, free testosterone, SHBG, and DHEA-S — not just a standard CBC or metabolic panel. GoodLife Health clinicians order and interpret this panel as part of their hormone evaluation; you don't need a referral or a specialist appointment.

One last thing

Testosterone in women follows a pattern that most guidelines still haven't caught up to: it declines continuously from the mid-20s onward, the symptoms it produces are identical to half a dozen other diagnoses, and there is no FDA-approved product that forces conventional medicine to take it seriously. That combination means millions of women spend years being told their labs are "normal" while living with a correctable deficiency. The fix is not complicated — it's a targeted lab panel, read by someone who knows what to look for, followed by a dose-appropriate protocol and consistent monitoring. That is exactly what GoodLife Health builds for every patient who comes in with this picture in 2026.

Related guides

• Testosterone replacement therapy for women — benefits and risks
• Testosterone therapy for women with low libido

References

1. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. 2015. doi.org/10.1210/jc.2015-2236
2. Testosterone in Women — The Clinical Significance (Lancet Diabetes & Endocrinology). 2015. doi.org/10.1016/S2213-8587(15)00284-300284-3)